Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu
{"title":"中国抗真菌皮癣菌管理专家共识（2024 年版）》。","authors":"Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu","doi":"10.1111/myc.13785","DOIUrl":null,"url":null,"abstract":"<p><p>Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13785"},"PeriodicalIF":4.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition).\",\"authors\":\"Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu\",\"doi\":\"10.1111/myc.13785\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.</p>\",\"PeriodicalId\":18797,\"journal\":{\"name\":\"Mycoses\",\"volume\":\"67 9\",\"pages\":\"e13785\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mycoses\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/myc.13785\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycoses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/myc.13785","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition).
Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.
期刊介绍：
The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi.
Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
